FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Farman-Farmaian Teymour M
2. Issuer Name and Ticker or Trading Symbol

Tapinator, Inc. [ TAPM ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

C/O TAPINATOR, INC., 110 WEST 40TH ST., SUITE 1902
3. Date of Earliest Transaction (MM/DD/YYYY)

8/21/2019
(Street)

NEW YORK, NY 10018
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  8/21/2019    M    13888  A  (1) 713888  D   
Common Stock  9/21/2019    M    13889  A  (1) 727777  D   
Common Stock  9/30/2019    D    27777  D  (2) 700000  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit   (1) 8/21/2019    M        13888    (3)  (3) Common Stock  13888  $0  236112  D   
Restricted Stock Unit   (1) 9/21/2019    M        13889    (3)  (3) Common Stock  13889  $0  222223  D   
Restricted Stock Unit   (1) 9/30/2019    D        222223    (3)  (3) Common Stock  222223   (2) 0  D   
Stock Option (right to buy)  $0.06  9/30/2019    A     250000       (4) 9/30/2029  Common Stock  250000  $0  250000  D   

Explanation of Responses:
(1)  Restricted stock units convert into common stock on a one-for-one basis.
(2)  Represents (i) the repurchase by the Issuer of undelivered common stock underlying 27,777 vested restricted stock units and (ii) the cancellation of the remaining 222,223 unvested restricted stock units. As consideration for the repurchase and cancellation of the shares of common stock and restricted stock units, respectively, the Reporting Person received (i) an option to purchase 250,000 shares of common stock (the same amount underlying the restricted stock units at the initial date of grant) at a per share exercise price of $0.06 and (ii) a one-time cash payment of $1,250.
(3)  On February 21, 2018, the Reporting Person was granted 250,000 restricted stock units, which began vesting ratably in 18 equal monthly installments on August 21, 2019.
(4)  This stock option vests as follows: (i) 50% in three substantially equal installments (with the first two installments rounded down for any fractional shares) on the last day of October, November, and December in 2019 (with the third installment including any fractional shares that were rounded down from the first and second installments) and (ii) the remaining 50% in 12 substantially equal installments (with the first 11 installments rounded down for any fractional shares) on the last day of each month in 2020 (with the 12th installment including any fractional shares that were rounded down from the first 11 installments).

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Farman-Farmaian Teymour M
C/O TAPINATOR, INC.
110 WEST 40TH ST., SUITE 1902
NEW YORK, NY 10018
X



Signatures
/s/ TEYMOUR FARMAN-FARMAIAN 10/2/2019
**Signature of Reporting Person Date


Tapinator (PK) (USOTC:TAPM)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Tapinator (PK) Charts.
Tapinator (PK) (USOTC:TAPM)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Tapinator (PK) Charts.
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....